Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: BMS, Incyte, Pharmather, Travere, Sihuan, Xuanzhu.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amneal, Biocryst, Biohaven, Brainchild, Cabaletta, Cure Rare, Ips, Kaerus, Merck, Mesoblast, Poltreg, Xspray.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Elucent Medical, GE Healthcare, Intalight.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Brightheart.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Beam, Hyundai, Regenxbio, Sarepta.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Apyx, Freespira, GE Healthcare, Know Bio, Prevencio, Rebrain.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Biodexa, Innocare, Thermosome, Valneva.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Alterity, JCR Pharmaceuticals, Teva.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Iaso, Meiragtx, UTR, Verastem.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bausch + Lomb.